0.71 (10.04%) 1d
Too speculative. They are a biopharma that develops drugs to neurological diseases, and that is the toughest thing to crack.
biotechnology / pharmaceutical
A clinical-stage biopharma that's trying to apply precision medicine to various nervous system diseases, a tough section of diseases to cure. Their lead drug aims to treat Alzheimer's and Parkinson's. Shares have tripled in recent years on positive data. But shares started to decline a year ago on unprofitable growth stocks like this. Shares have doubled since May due to positive clinical trial data. He doesn't recommend unprofitable companies, but that is the cost of business for early-stage biotech companies. He likes parts of this, but can't recommend this yet, and prefers a surer thing, Eli Lilly. A spec buy.
biotechnology / pharmaceutical
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Anavex Life Sciences(AVXL-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 2

Stockchase rating for Anavex Life Sciences is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Anavex Life Sciences(AVXL-Q) Frequently Asked Questions

What is Anavex Life Sciences stock symbol?

Anavex Life Sciences is a American stock, trading under the symbol AVXL-Q on the NASDAQ (AVXL). It is usually referred to as NASDAQ:AVXL or AVXL-Q

Is Anavex Life Sciences a buy or a sell?

In the last year, 2 stock analysts published opinions about AVXL-Q. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Anavex Life Sciences.

Is Anavex Life Sciences a good investment or a top pick?

Anavex Life Sciences was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Anavex Life Sciences.

Why is Anavex Life Sciences stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Anavex Life Sciences worth watching?

In the last year, there was no coverage of Anavex Life Sciences published on Stockchase.

What is Anavex Life Sciences stock price?

On 2023-11-27, Anavex Life Sciences (AVXL-Q) stock closed at a price of $6.36.